We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$317M
AUM Growth
+$38.8M
Cap. Flow
-$1.56B
Cap. Flow %
-492.71%
Top 10 Hldgs %
57.22%
Holding
73
New
24
Increased
15
Reduced
14
Closed
19

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$15.5M
2
EHC icon
Encompass Health
EHC
+$10.3M
3
COR icon
Cencora
COR
+$9.71M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.22M
5
BDX icon
Becton Dickinson
BDX
+$8.96M

Top Sells

Rank Stock Value
1
RCM
R1 RCM Inc. Common Stock
RCM
+$24.4M
2
HCA icon
HCA Healthcare
HCA
+$18M
3
JNJ icon
Johnson & Johnson
JNJ
+$13.9M
4
CRL icon
Charles River Laboratories
CRL
+$9.93M
5
WMGI
Wright Medical Group Inc
WMGI
+$7.59M

Sector Composition

Rank Sector Weight
1 Healthcare 89.13%
2 Industrials 1.01%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
51
CALL
Aclaris Therapeutics
ACRS
$772M
$94K 0.03%
+376,200
New +$623K
RNAC icon
52
Cartesian Therapeutics
RNAC
$231M
$61K 0.02%
+860
New +$41.5K
ACHC icon
53
Acadia Healthcare
ACHC
$2.85B
– –
-23,918
Closed -$743K
ATRC icon
54
AtriCure
ATRC
$1.97B
– –
-34,391
Closed -$858K
AZN icon
55
AstraZeneca
AZN
$245B
– –
-15,516
Closed -$1.38M
BIO icon
56
Bio-Rad Laboratories Class A
BIO
$8.96B
– –
-6,910
Closed -$2.3M
CRL icon
57
Charles River Laboratories
CRL
$11.1B
– –
-74,986
Closed -$9.93M
HAE icon
58
Haemonetics
HAE
$3.94B
– –
-32,594
Closed -$4.11M
HCA icon
59
HCA Healthcare
HCA
$88B
– –
-149,755
Closed -$18M
HUM icon
60
Humana
HUM
$45B
– –
-3,899
Closed -$997K
IART icon
61
Integra LifeSciences
IART
$1.39B
– –
-84,225
Closed -$5.06M
INSP icon
62
Inspire Medical Systems
INSP
$1.5B
– –
-30,805
Closed -$1.88M
JNJ icon
63
Johnson & Johnson
JNJ
$613B
– –
-107,413
Closed -$13.9M
SNY icon
64
Sanofi
SNY
$103B
– –
-67,200
Closed -$3.11M
TAK icon
65
Takeda Pharmaceutical
TAK
$53.7B
– –
-92,273
Closed -$1.59M
AXNX
66
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-27,759
Closed -$747K
PETQ
67
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
– –
-34,354
Closed -$936K
SIEN
68
DELISTED
Sientra, Inc.
SIEN
– –
-52,995
Closed -$3.43M
IIN
69
DELISTED
IntriCon Corporation
IIN
– –
-73,543
Closed -$1.43M
XENT
70
DELISTED
Intersect ENT, Inc
XENT
– –
-37,815
Closed -$643K
NTGN
71
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
– –
-193,052
Closed -$332K
1 2
3

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Endurant Capital Management held 73 positions worth $317M, up 14% from $279M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Endurant Capital Management withdrew a net $1.56B in Q4 2019, closing 19 positions and reducing 14 holdings. Its most notable exit was HCA Healthcare, an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 77% a quarter earlier, followed by Industrials and Technology.

Against the trend, Endurant Capital Management opened a new position in Regeneron Pharmaceuticals worth $10.3M.

  • Endurant Capital Management's largest Q4 2019 buy was Regeneron Pharmaceuticals: 27,390 shares worth $10.3M.
  • Endurant Capital Management added most to Elevance Health in Q4 2019, an estimated $15.5M increase.
  • Endurant Capital Management's biggest Q4 2019 reduction was R1 RCM Inc. Common Stock, cutting an estimated $24.4M.
  • Endurant Capital Management fully exited HCA Healthcare in Q4 2019, selling an estimated $18M.
  • Endurant Capital Management's ten largest holdings make up 57% of its $317M portfolio in Q4 2019.
  • Endurant Capital Management opened 24 new positions and closed 19 in Q4 2019.
  • Endurant Capital Management's portfolio value rose 14% quarter-over-quarter to $317M.

Based on Endurant Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.